Drawing for BLOREAM

USPTO serial 79253879

BLOREAM

Reviewed by CopyMark Law Group

Reg. 5958313Status 709
Filing date
Status date
Registration date
Jan 14, 2020
Examiner
MCMORROW, JANICE LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLOREAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceuticals for the for the prevention and the treatment of neuropsychiatric diseases, immune-inflammatory diseases, cardiovascular diseases, diabetes and cancers; medical preparations, namely, diagnostic preparations for medical purposes; veterinary preparations for the prevention and the treatment of neuropsychiatric diseases, immune-inflammatory diseases, cardiovascular diseases, diabetes and cancers; sanitary preparations for medical use; dietetic foods and beverages for medical or veterinary use, food for babies; food supplements for humans and animals; plasters, wound dressings; material for dental fillings and dental impressions; disinfectant preparations for destroying vermin; fungicides, herbicidesSECTION 71 - CANCELLED—
009Scientific, optical, weighing, measuring, signaling, checking, supervision, life-saving and teaching apparatus and instruments, namely, computers, microscopes for scientific or research purposes in the fields of neuropsychiatric diseases, immune-inflammatory diseases, cardiovascular diseases, diabetes and cancers; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; computers; data processing equipment; software recorded on magnetic media or downloaded from a remote computer network for controlling and managing patient medical information; personal digital assistant; transmitters of electronic signals; video cameras; activity sensors; downloadable applications for mobile devices to enable users to track their symptoms, physical activity and vital signs and to record and share information with healthcare professionals; spectacles, contact lenses; in-ear headphones; virtual reality helmetsSECTION 71 - CANCELLED—
010medical, apparatus, instruments and equipment, namely, medical devices for monitoring vital signs, blood properties and respiratory events; artificial teeth, eyes, organs and limbs; orthopedic supports; suture material; compression stockings, tights and socks; stockings, tights and socks for varicose veins; syringes for medical use; medical measuring instruments, particularly instruments able to directly transmit data to a database, particularly fever measuring instruments, heart rate monitors; nanorobots for medical use; blood testing apparatus; endoscopic video capsules; medical apparatus for measuring biochemical changes in blood; blood biomarker devices; inhalers; blood pressure monitorsSECTION 71 - CANCELLED—
035Assistance in running or managing a commercial venture; business management assistance services; database management; computer file management; compilation of information in computer databases; updating and maintenance of data in computer databases; business management and organization consultancy; business management consultancy; analysis of commercial data; market studies; information relating to market research; commercial intermediary services in the context of linking potential private investors with entrepreneurs looking for financing; expertise in business productivity; sales promotion services for others; public relations; sponsorship search; auctioneering services; organization of events for commercial or advertising purposes; providing of personnel; collection of business informationSECTION 71 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory services relating to health; telemedicine services; medical diagnosis services; home care services; individualized medical prescription services; online medical prescription services; consultancy in relation to medical treatment in the home; advice relating to self-medication; provision of medical information to patients; remote medical examination servicesSECTION 71 - CANCELLED—
045Providing support in the monitoring of patients receiving medical treatment, namely, emotional support; social networking servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2026C71TCANCELLED SECTION 71—
Jan 14, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 22, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 27, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 27, 2020FIMPFINAL DISPOSITION PROCESSED—
Apr 14, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 14, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 9, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 9, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2019ALIEASSIGNED TO LIE—
Sep 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 12, 2019RFNTREFUSAL PROCESSED BY IB—
Mar 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 14, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 13, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2019DOCKASSIGNED TO EXAMINER—
Mar 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 7, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance